Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03850535 |
|---|---|
| Brief Title: | A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission |
| First Submitted : | February 20, 2019 |
| First Submitted that Met QC Criteria : | February 20, 2019 |
| First Posted : | February 21, 2019 |
| Last Update Submitted that Met QC Criteria : | October 8, 2020 |
| Last Update Posted : | October 12, 2020 |